A012790 Stock Overview
Manufactures and sells pharmaceutical products in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Sinil Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,590.00 |
| 52 Week High | ₩8,430.00 |
| 52 Week Low | ₩6,400.00 |
| Beta | 1.51 |
| 11 Month Change | -12.13% |
| 3 Month Change | -16.48% |
| 1 Year Change | -9.23% |
| 33 Year Change | -36.40% |
| 5 Year Change | 11.01% |
| Change since IPO | 509.54% |
Recent News & Updates
Recent updates
Little Excitement Around Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Earnings
Aug 12
Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?
Mar 11Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?
Feb 13
Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?
Jan 17Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?
Dec 22Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Nov 26Shareholder Returns
| A012790 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -1.2% | -6.3% | -0.7% |
| 1Y | -9.2% | 5.5% | -4.1% |
Return vs Industry: A012790 underperformed the KR Pharmaceuticals industry which returned 5.5% over the past year.
Return vs Market: A012790 underperformed the KR Market which returned -4.1% over the past year.
Price Volatility
| A012790 volatility | |
|---|---|
| A012790 Average Weekly Movement | 3.8% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A012790 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A012790's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | n/a | Mi-Keun Jung | www.sinilpharm.com |
Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services.
Sinil Pharmaceutical Co., Ltd. Fundamentals Summary
| A012790 fundamental statistics | |
|---|---|
| Market cap | ₩74.97b |
| Earnings (TTM) | ₩15.07b |
| Revenue (TTM) | ₩91.70b |
5.0x
P/E Ratio0.8x
P/S RatioIs A012790 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A012790 income statement (TTM) | |
|---|---|
| Revenue | ₩91.70b |
| Cost of Revenue | ₩51.67b |
| Gross Profit | ₩40.03b |
| Other Expenses | ₩24.96b |
| Earnings | ₩15.07b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.32k |
| Gross Margin | 43.65% |
| Net Profit Margin | 16.43% |
| Debt/Equity Ratio | 0% |
How did A012790 perform over the long term?
See historical performance and comparison